New immunological approaches to the application of BCG vaccine for the treatments of tumors (acute leukoses).
D000818:Animals; D000906:Antibodies; D000956:Antigens, Viral / Q000008:administration & dosage; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D001667:Binding, Competitive; D003520:Cyclophosphamide / Q000627:therapeutic use; D003601:Cytotoxicity Tests, Immunologic; D000939:Epitopes; D005620:Freund's Adjuvant / Q000008:administration & dosage; D009052:Leukemia Virus, Murine / Q000276:immunology*; D007942:Leukemia, Experimental / Q000276:immunology / Q000628:therapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009929:Organ Size; D013154:Spleen / Q000033:anatomy & histology; D013997:Time Factors
D000906:Antibodies; D000956:Antigens, Viral; D001500:BCG Vaccine; D000939:Epitopes; D003520:Cyclophosphamide; D005620:Freund's Adjuvant